Rituximab therapy effective for ANCA-associated vasculitis Phys.Org In an article published today in the New England Journal of Medicine, Immune Tolerance Network (ITN) researchers demonstrated that a single course of rituximab therapy (anti-CD20; Rituxan, Genentech, Inc.) is as effective as the current standard of ... NIH-funded study finds that rituximab is as effective as standard therapy for ... Keeping Vasculitis at Bay Rituxan Helps in Vasculitis Over Long Term |
